Related Experiment Video
Updated: Aug 17, 2026

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
[Basics of molecular diagnostics and therapy of malignant tumors]
1Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Charité-Universitätsmedizin Berlin, Campus Virchow Klinikum, Humboldt Universität, Berlin, Germany. pdaniel@mdc-berlin.de
Abstract:
Recent insights in disease pathogenesis and mechanisms of resistance to therapy of malignant tumors provide a rational basis for the development of novel therapeutic strategies that target genetic defects and deregulated signaling events in malignant tumors. In contrast to conventional therapeutics, small molecule inhibitors or monoclonal antibodies allow for a far more selective, targeted therapy of tumors that carry a corresponding target structure or gene expression profile. Molecular therapeutics therefore necessitate clinical deployment of genetic diagnostics for the identification of those patients who have a chance to benefit from these novel targeted therapies.
Insights
Novel cancer therapies target specific genetic defects and signaling pathways, offering more selective treatment options. Genetic diagnostics are crucial for identifying patients who will benefit from these targeted molecular therapeutics.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Advances in understanding cancer pathogenesis and therapeutic resistance.
- Limitations of conventional cancer treatments.
Purpose:
- To outline the rationale for developing novel targeted cancer therapies.
- To highlight the role of molecular diagnostics in personalized medicine.
Summary:
- Novel therapeutics target specific genetic defects and signaling pathways in malignant tumors.
- Small molecule inhibitors and monoclonal antibodies offer selective tumor targeting.
- Molecular therapeutics require genetic diagnostics to identify suitable patient populations.
Impact:
- Enables personalized medicine approaches in oncology.
- Improves treatment efficacy by targeting specific molecular profiles.
- Facilitates the clinical translation of molecular insights into patient care.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer
Tumor Immunotherapy
